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Voltage-dependent K+ channels (Kv) are involved in the proliferation of many types of cells, but the mechanisms by which their activity is
related to cell growth remain unclear. Kv antagonists inhibit the proliferation of mammalian cells, which is of physiological relevance in skeletal
muscle. Although myofibres are terminally differentiated, some resident myoblasts may re-enter the cell cycle and proliferate. Here we report that
the expression of Kv1.5 is cell-cycle dependent during myoblast proliferation. In addition to Kv1.5 other Kv, such as Kv1.3, are also up-regulated.
However, pharmacological evidence mainly implicates Kv1.5 in myoblast growth. Thus, the presence of S0100176, a Kv antagonist, but not
margatoxin and dendrotoxin, led to cell cycle arrest during the G1-phase. The use of selective cell cycle blockers showed that Kv1.5 was
transiently accumulated during the early G1-phase. Furthermore, while myoblasts treated with S0100176 expressed low levels of cyclin A and D1,
the expression of p21cip-1 and p27kip1, two cyclin-dependent kinase inhibitors, increased. Our results indicate that the cell cycle-dependent
expression of Kv1.5 is involved in skeletal muscle cell proliferation.
© 2008 Elsevier B.V. All rights reserved.Keywords: Cell cycle; Myoblasts; Potassium channels; Proliferation; Skeletal muscle1. Introduction
Voltage-dependent potassium channels (Kv) control the
repolarization of action potential, and thus the electrical
excitability of nerve and muscle [1]. They are also involved
in activation, apoptosis and proliferation, among other functions
in mammalian cells [2]. Increasing evidence implicates Kv in
cell differentiation and cell cycle control [2,3]. Non-specific
drugs, such as 4-AP and TEA, lead to cell cycle arrest. Although
no direct evidence of the mechanism has been provided, the use
of these compounds suggests that the control of Kv may involve
some cyclin-dependent kinase inhibitors (CDKIs) [3–6]. The
CDKIs p21cip-1 and p27kip1 control the G1/S transition through
binding to cyclin D1–cdk4/6 and cyclin A–cdk2 complexes. In⁎ Corresponding author. Tel.: +34 934034616; fax: +34 934021559.
E-mail address: afelipe@ub.edu (A. Felipe).
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doi:10.1016/j.bbamcr.2008.01.001addition, while cyclin D1 regulates G1 progression, the cyclin
A–cdk2 complex is active during the S-phase [7].
Experimental evidence indicates that membrane potential
changes during cell growth: highly proliferating cells are more
depolarized than normal or quiescent cells. Kv mostly generate
hyperpolarization by extrusion of K+ from the cell. Thus, during
the first phases of the cell cycle (G1 or G1/S transition) transient
hyperpolarization due to ion channels and, particularly, Kv may
be needed. One explanation for this would be that Kv control a
specific check point during these stages; this control would
involve changes in membrane potential, cell volume and Ca2+
influx. Sometimes, the blocker concentration of the channel to
inhibit cell growth is higher than the IC50 for the activity [2,3,8].
In this context, new results suggest non-conducting roles for
voltage-gated ion channels controlling cellular functions
including proliferation [9,10].
Kv1.3 andKv1.5 Shaker subunits are involved inmacrophage
and astrocyte proliferation [11–13]. While Kv1.3 promotes cell
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research with Kv1.5 difficult [4,14,15]. In addition to leukocytes
and oligodendrocyte progenitors, proliferation is an important
characteristic of skeletal muscle. Although muscle fibres are
formed by terminally differentiated myotubes [16], quiescent
muscle cells may re-enter the cell cycle in tissue regeneration, or
in cancer. Kv1.3 andKv1.5 are both expressed in skeletal muscle,
the latter being the most abundant [17,18]. While Kv1.3 is
involved in peripheral insulin sensitivity, Kv1.5, a classical
muscle channel, acts during repolarization [17,18]. Since Kv1.5
is involved in glial proliferation [4], the knowledge of Kv1.5-
related cell cycle control mechanisms is of physiological
relevance. Although the use of non-specific compounds, such
as TEA and 4-AP, has yielded interesting results the role of Kv1.5
remains the subject of debate. Different Kv subunits have been
implicated in the proliferation of distinct mammalian cells
[4,6,12,13]. Here we report that Kv1.3 and Kv1.5 are up-
regulated during proliferation at the G1 phase in myoblasts.
Furthermore, by using a combination of pharmacological tools
we provide evidence that Kv1.5 is involved in skeletal muscle
proliferation by controlling G1-phase progression through a
mechanism that involves the CDKIs p21cip-1 and p27kip1, and
cyclins A and D1. This is the first time that a Kv subunit has been
related to the control of cell cycle progression in muscle, and we
also analysed underlying mechanisms. Our results may help to
understand the signalling pathways involved in Kv control of cell
cycle progression in skeletal muscle. Since Kv1.5 is considered a
good target in muscle, and K+ channel blockers are being
considered as newpharmacological tools in anti-cancer therapies,
knowledge of the role of Kv1.5 in muscle proliferation is crucial.Fig. 1. L6E9 myoblasts express Kv1.3 and Kv1.5. mRNA expression of Kv1.5 (A) an
panels, 18S. (C) PCR reactions in L6E9 myoblasts were performed in the presence (+R
skeletal muscle; L, liver. (D) Kv1.3 and Kv1.5 protein expression in myoblasts. West
control antigen peptide. (E) Representative immunofluorescence images of Kv1.5 an
Right panels represent pre-serum (Kv1.5) and secondary antibody (Kv1.3) controls.2. Materials and methods
2.1. Materials and antibodies
Recombinant margatoxin (MTX) and α-dendrotoxin (DTX) were from
Alomone. S0100176 was kindly donated by Sanofi-Aventis. 4-aminopyridine
(4-AP), hydroxyurea and mimosine were purchased from Sigma. Polyclonal
anti-Kv1.3 and anti-Kv1.5 antibodies were obtained from Alomone. Anti-Kv1.5
used in immunofluorescence studies was kindly donated by Michael M. Tamkun
(Colorado State University). Cyclin A, cyclin D1, p21
cip-1 and p27kip1 antibodies
were from Santa Cruz. Monoclonal anti-β-actin (Sigma) was used as control.
CY3 secondary antibody was from GE Healthcare. All other reagents and
materials were of analytical grade.
2.2. Cell culture
The rat skeletal muscle-derived L6E9 cell line was kindly provided by Dr. B.
Nadal-Ginard (Cardiovascular Institute and Center for Cardiovascular Health,
Mount Sinai School of Medicine, NY). Myoblasts were grown in Dulbecco's
modified medium (DMEM) supplemented with 10% (v/v) foetal bovine serum
(FBS), 10 U/ml penicillin and streptomycin, 2 mM L-glutamine, and 25 mM
HEPES (pH7.4). Myoblasts were arrested at G0 by serum deprivation (resting) in
DMEM supplemented with 0.2% BSA for at least 36 h. G0-arrested cells were
further incubated in the absence or presence of DMEM supplemented with 10%
FBS for the indicated times. In some experiments, aqueous solutions ofMTX,DTX,
4-AP and S0100176 (in DMSO) were simultaneously added to the media. DMSO
controls were performed and no differences were found at the concentrations used.
2.3. RNA isolation, RT-PCR analysis and real-time PCR
Total RNA from rat tissues (brain, heart, skeletal muscle and liver) and L6E9
cells was isolated using Tripure reagent (Roche Diagnostics). All animal
handling was approved by the ethics committee of the University of Barcelona in
accordance with EU regulations. RNA was treated with DNase I and PCR
controls were performed in the absence of reverse transcriptase. cDNA synthesisd Kv1.3 (B) in L6E9 cells and rat tissues. Top panels, Kv1.5 and Kv1.3; bottom
T) or absence (−RT) of the reverse transcriptase reaction. H, heart; B, brain; SK,
ern blot analysis was performed in the presence (+AP) and absence (−AP) of the
d Kv1.3 in cycling L6E9 myoblasts. Top panels: Kv1.5; bottom panels: Kv1.3.
Channels were detected as a punctuate pattern. Bar represents 10 μm.
Fig. 2. Proliferation and cell cycle analysis of L6E9 myoblasts after FBS re-
addition. Resting cells were incubated for 24 h in the absence (○) or presence of
FBS (●). Sample collection was performed as described in the Experimental
section. (A) Time course of 3H-thymidine incorporation. (B) Cell count after
FBS re-addition. Values are the mean±SEM of three different assays, each
performed in triplicate. (C) Cell cycle analysis with propidium iodide.
Exponentially growing cells at 24 h appear in the graph with two peaks
corresponding to the G0/G1 phase and cells with double DNA content in the G2/M
phase. Top: representative histograms at 0, 6, 18 and 24 h after FBS re-addition;
bottom: table showing cell cycle distribution (%). Values are the mean±SEM of
10 different assays.
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hexanucleotide and oligo dT, according to the manufacturer's instructions. Once
cDNAwas synthesized, the conditions were set for further PCR: 92 °C for 30 s,
55 °C for 1 min and 72 °C for 2 min. These settings were applied for 30 cycles.
Primer sequences and accession numbers (AN) were: Kv1.3 (AN: M30441), F:
5′-CTC ATCTCCATTGTCATCTTCTGA-3′ and R: 5′-TTGAATTGGAA
ACAATCAC-3′ (base pairs length 718); Kv1.5 (AN: AF302768), F: 5′-
GGATCACTCCATCACCAG-3′, R: 5′-GGCTTCCTCCTCTTCCTTG-3′ (base
pairs length: 334). Ten microliters from the final RT-PCR reactions were
electrophoresed in a 1% agarose TBE gel (40 mMTris, 20 mM acetic acid, 1 mM
EDTA, pH 8.0).
Real-time PCR was performed using a LightCycler machine (Roche) with
LightCycler FastStart DNA MasterPLUS SYBR Green I (Roche), according to the
manufacturer's instructions. PCR primers were: Kv1.5, F: 5′-TCCGACGGCTG-
GACTCAATAA-3′; R: 5′-CAGATGGCCTTCTAGGCTGTG-3′ (base pairs
length 133); Kv1.3, F: 5′-AGTATATGGTGATCGA AGAGG-3′; R: 5′-AGT-
GAATATCTTCTTGATGTT-3′ (base pairs length 136). The reactions were
performed under the following conditions: 95 °C for 5 s, 55 °C for 8 s, and
72 °C for 9 s, preceded by 10min at 95 °C and followed by 10min at 95 °C.Melting
curves were performed to verify the specificity of the product and 18S (AN:
X00686), F: 5′-CGCAGAATTCCCAC TCCCGACCC-3′, R: 5′-CCCAAGCTC-
CAACTACGAGC-3′ (base pairs length 212), was included as an internal reference,
as previously described [12,13,19–21]. Results were analysed with Light Cycler
software 3.5 (Roche). For each primer set, a standard curve was made and the slope
factor calculated. Values were normalized to the corresponding 18S. The
corresponding real-time PCR efficiency (E) of one cycle in the exponential phase
was calculated according to the equation.: E=10(−1/slope). The normalized Kv1.5/
Kv1.3 ratio was calculated as follows: Ratio=(1+E) ΔCt (Kv1.5) / (1+E) ΔCt (Kv1.3),
where Ct signifies the threshold cycle.
2.4. Membrane protein extracts and Western blot
Cells were washed in cold phosphate-buffered saline (PBS) and lysed on ice
with lysis solution (1% NP40, 10% glycerol, 50 mmol/L HEPES pH 7.5,
150 mmol/L NaCl), supplemented with 1 μg/ml aprotinin, 1 μg/ml leupeptin,
86 μg/ml iodoacetamide, 0.1% pepstatin and 1 mM phenylmethylsulfonyl fluoride
as protease inhibitors. Samples (50μg)were boiled in Laemmli SDS loading buffer
and separated on 10% SDS-PAGE, transferred to PVDF membranes (Immobilon-
P, Millipore) and blocked in 5% dry milk-supplemented 0.05% Tween 20 PBS
before immunoreaction. Filters were immunoblotted with the antibodies described
above. The specificity of Kv1.3 and Kv1.5 commercial antibodies was tested with
control antigen peptides provided by the manufacturer. Densitometric analysis of
the filters was performed by Phoretix software (Nonlinear Dynamics). Results are
presented as the mean±SEM of each experimental group.
2.5. Immunolocalization
L6E9 cells fixed with 4% paraformaldehyde in PBS for 10 min were further
permeabilized with 0.1% Triton X-100/PBS for 10 min. After 60 min incubation
with blocking solution (10% goat serum/5%non-fat drymilk/0.75%TritonX-100/
PBS), cells were reacted with antibodies in 10% goat serum/0.75% Triton X-100/
PBS for 90 min. Rabbit antiserum specificity against Kv1.5 has been previously
described [22]. Cells were further incubatedwith CY3 anti-rabbit antibody in PBS.
2.6. Proliferation assays
DNA synthesis was determined by the incorporation of 3H-thymidine (GE
Healthcare) into DNA. L6E9 cells (2×105) were cultured in 6-well plates
without FBS, supplemented with 0.2% BSA, for 36 h. Cells were further
maintained for 24 h in the absence (resting) or presence (proliferation) of 10%
FBS with/without toxins or chemicals. Finally, this was replaced by the same
medium containing 1 μCi/ml [3H]-thymidine. After 3 h, cells were fixed in cold
methanol, washed three times in ice-cold 10% trichloracetic acid, and
solubilized in 1% SDS and 0.3% NaOH. The content of the well was used for
counting radioactivity. Semimaximal inhibition (EC50) was calculated as
follows: Y=min+(max−min) / (1+exp(log EC50−X). X represents the loga-
rithm of concentration and Y the response.For cell counting, L6E9 cells (4×104) were seeded in 24-well plates and
cultured as above. Cells were washed twice in PBS and treated with 150 μl of
trypsin and counted.
2.7. TUNEL assay
The in situ cell death detection assay kit was purchased fromRoche. The assay
was performed according to the manufacturer's instructions. The percentage of
apoptotic cells was calculated by counting the number of TUNEL-positive nuclei
out of 500 total cells for each sample. At least three randomly chosen fields were
assessed. The percentage of TUNEL-positive nuclei was determined in three
independent experiments. Cells were visualised at ×40 magnification.
2.8. Cell cycle analysis and membrane potential measurements by
flow cytometry
DNA content for cell cycle analysis of fixed cells was performed with
propidium iodide (PI). Cells were collected in 5 ml PBS and spun during 5 min
at 200 ×g. Using a Pasteur pipette, cells were resuspended in 0.5 ml PBS and
further fixed in ice-cold 70% ethanol for at least 2 h. Fixed cells were next
centrifuged at 200 ×g for 5 min and the pellet was resuspended in 1 ml of freshly
prepared PI staining solution (20 μg/ml PI/0.1% Triton/0.2 mg DNase-free
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4 °C overnight in the dark. Flow cytometric measurements were carried out
using an Epics XL flow cytometer (Coulter Corporation). The instrument was
set up with the standard configuration: excitation of the sample was done using a
standard 488 nm air-cooled argon–ion laser at 15 mW power. Forward scatter
(FSC), side scatter (SSC) and red (620 nm) fluorescence for PI were acquired.
Optical aligment was based on optimized signal from 10 nm fluorescent beads
(Immunocheck, Epics Division). Time was used as a control of the stability of
the instrument. Red fluorescence was projected on a 1024 monparametrical
histogram. Agregates were excluded gating single cells by their area vs. peak
fluorescence signal and 10,000 cells were counted in each group. DNA analysis
(ploidy analysis) on single fluorescence histograms was done using Multicycle
software (Phoenix Flow Systems).
To measure the membrane potential, myoblasts were cultured as described
above. Cells were exposed to 75 mM KCl, 20 μM S0100176 and 2 mM 4-AP.
Two hundred fifty nanomolar bis-(1,3-dibutylbarbituric acid) trimethine oxonol
(DiBAC4(3)) dye (Molecular Probes) was added to the cells, and 5 min later the
fluorescence intensity of the cell population was analysed with the flow
cytometer at 488 nm wavelength excitation. DiBAC4(3) was prepared in DMSO
according to the manufacturer's instructions.
2.9. Statistics
Values are expressed as the mean±SEM. Significance was tested by the
Student's t test or ANOVA (GraphPad, PRISM 4.0), as appropriate. A value of
pb0.05 was considered significant.
3. Results
3.1. L6E9 myoblasts express Kv1.5 and Kv1.3
Voltage-dependent K+ channels (Kv) play crucial roles in
skeletal muscle physiology [23,24]. L6E9 myoblasts expressedFig. 3. FBS-dependent proliferation induces Kv1.3 and Kv1.5 in myoblasts. Resting c
the addition of FBS and Kv1.3 and Kv1.5 expression was analysed. (A) Kv1.3 (○)
Values are the mean±SEM (n=4). Significant differences were found with Kv1.3 a
variation in arbitrary units (AU) were normalized to 18S relative quantity (RQ) as f
Kv1.3 at 0 h RQ/18S RQ at 0 h). (B) Kv1.3 and Kv1.5 protein expression in L6E9 m
relative β-actin expression. Symbols are: (○, right Y axis), Kv1.3; (●, left Y axis),
Student's t test). AU, arbitrary units. (D) Representative immunofluorescence imag
Arrows identify Kv1.5 as a punctuate pattern. Bars indicate 10 μm scale.Kv1.5 andKv1.3 (Fig. 1). Both channels were detected in cycling
L6E9 myoblasts by RT-PCR (panels A–C), Western blot (panel
D) or immunocytochemistry (panel E). RT-PCR also revealed
both isoforms in skeletal muscle (SK). While heart (H) and brain
(B) were positive controls for Kv1.5 and Kv1.3, respectively,
liver (L) was negative. Real-time PCR demonstrated that while
the expression of Kv1.5 was abundant, the relative amount of
Kv1.3 was very low. The Kv1.5/Kv1.3 ratio in myoblasts ranged
from 65 fold in resting cells to 120 fold at 6 h of proliferation.
3.2. Analysis of L6E9 myoblast proliferation
L6E9 cells were incubated in the presence or absence of serum
(FBS) and proliferation was analysed (Fig. 2). By removing FBS
for 36 h, myoblasts stopped cell growth. Fig. 2A shows that a
further 24 h of incubation in the absence of FBS did not result in
an increase of 3H-thymidine incorporation into DNA. The re-
addition of 10% FBS to the culture led to myoblast proliferation.
This result was further confirmed by the number of cells (Fig. 2B).
While arrested cells did not increase in culture, the amount of
proliferating myoblasts steadily increased. Thus, 3H-thymidine
incorporation and cell number indicated that myoblasts were G0-
arrested by removing the serum, while its re-addition triggered
proliferation. In order to characterize this further, we performed a
flow cytometry analysis (Fig. 2C). Eighty percent of the cells were
G0/G1-arrested by FBS withdrawal. In addition, no sub-G1 peak
was detected, thus indicating that apoptosis was irrelevant in our
experimental conditions. This was confirmed with a TUNEL
assay. The percentage of cells that expressed TUNEL-positiveells were incubated for 24 h in the presence of FBS. Samples were collected after
and Kv1.5 (●) relative mRNA expression by real-time PCR at indicated times.
nd Kv1.5 at 6 h ( pb0.01 vs. 0 h, Student's t test). Using standard curves, fold
ollows: (Kv1.5 or Kv1.3 RQ at different times (DT) /18S RQ at DT)/(Kv1.5 or
yoblasts. (C) Quantification of data in panel B. Values were normalized to the
Kv1.5. Significant differences were found with Kv1.5 at 6 h ( pb0.05 vs. 0 h,
es of Kv1.5 in L6E9 myoblasts at 0 h (resting) and 6 h after FBS re-addition.
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ence or the absence of FBS respectively. In the presence of FBS,
myoblasts re-entered the cell cycle. While the number of cells at
G0/G1 was steadily reduced, myoblasts in the S-phase increased
until 18 h. After 24 h of serum addition, cells at G2/M increased.
3.3. Myoblast proliferation induces Kv1.5 expression
Many Kv are induced during cell proliferation [2,3,8]. Thus,
Kv1.3 and Kv1.5 increase with proliferation in macrophages andFig. 4. Kv1.5 participates during G1 progression of the cell cycle in L6E9 myoblasts.
(+FBS). (A) % of inhibition of 3H-thymidine incorporation in the presence of increas
of 100 nMmargatoxin (MTX), 1 μM α-dendrotoxin (DTX) and 20 μM S0100176 (S0
vs. FBS (Student's t test). (D) % inhibition of 3H-thymidine incorporation in the pr
performed in triplicate. (E) Cell cycle analysis in the presence of S0100176 (20 μM)
showing cell cycle distribution (%). Values are the mean of four different assays eac
DiBAC4(3) fluorescence was measured at different time points (0, 3, 6, 9, 14, 18 and 2
(●, KCl), 20 μM S0100176 (■, S01) and 2 mM 4-AP (□, 4-AP). Values are the mastrocytes respectively [4,11,12]. Fig. 3 shows that Kv1.3 and
Kv1.5 expression increased duringmyoblast proliferation. Kv1.5
and Kv1.3 mRNA peaked at 6 h (Fig. 3A). While Kv1.3
increased almost 2.5 fold, Kv1.5 expression rose 3.5 fold. Similar
results were observed in protein abundance (Fig. 3B and C).
Kv1.5 peaked more than 3 fold at 6 h, whereas Kv1.3 was only
induced 1.5 fold. To further confirm this we conducted indirect
immunofluorescence studies. Unlike Kv1.5, the low expression
of Kv1.3 impaired this approach. As shown in Fig. 3D, and in
agreement with real-time PCR and Western blot, Kv1.5,Resting cells were cultured for 24 h in the absence (−FBS) or presence of serum
ing concentrations of 4-AP. (B) % proliferation in the absence (FBS) or presence
1). DMSO was used as a control. (C) Cell count. Legend as panel B. ⁎⁎, pb0.01
esence of S0100176. Values are the mean±SEM of four different assays, each
and 4-AP (2 mM). Top: histograms after 24 h of FBS re-addition; bottom: table
h performed in triplicate. (F) Membrane potential changes during the cell cycle.
4 h) after FBS re-addition in the absence (○, FBS) or the presence of 75 mMKCl
ean±SEM of four different experiments each performed in triplicate.
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addition, which corresponds to the G1-phase progression of the
cell cycle.
3.4. Kv1.5 is involved in myoblast proliferation
The role of K+ channels in cell cycle progression is under
study. While Kv1.3 has a pivotal role during leukocyte growth,
the function of Kv1.5 in glial proliferation is under debate
[4,12,25]. Discrepancies could be explained by a switch between
Kv1.5 and Kv1.3 during the proliferating phenotype [26].
However, homotetrameric Kv1.5 has no apparent role in
macrophage proliferation [12,13]. In this context, we sought to
determine whether Kv1.5 played a role in skeletal muscle cell
growth. Although Kv1.5 studies are difficult due to the lack of
specific antagonists [14] we undertook a novel pharmacological
approach. Margatoxin (MTX) potently inhibits Kv1.3, but also
blocks Kv1.1, Kv1.2 and Kv1.6 [27]. Similarly, α-Dendrotoxin
(DTX) inhibits most Kv but not Kv1.5 [28]. However,
S0100176, a Kv blocker, is a Kv1.5 antagonist at the micromolar
range [29]. Fig. 4 shows that by using this combination of toxins
and chemicals we were able to demonstrate that Kv channels,Fig. 5. G1 and S-arrest of L6E9 myoblasts leads to Kv1.5 accumulation. Resting ce
without or with 0.5 mMmimosine (Mi) and 1.3 mM hydroxyurea (HU). (A) Cell cycle
distribution (%). Values are the mean±SEM of four different assays each performed
proliferating cells; Mi, mimosine; HU, hydroxyurea. (D) Quantification of data in p
normalized to the relative β-actin expression, are the mean±SEM of four differentand particularly Kv1.5, were involved in G1-arrest of myoblasts.
4-aminopyridine, a non-specific Kv blocker, inhibited prolifera-
tion with a semimaximal inhibition (EC50) of 2.5±0.5 mM
(Fig. 4A), indicating that K+ channels played a pivotal role. We
then incubated cells in the presence of MTX, DTX and
S0100176. Fig. 4B shows that only the presence of S0100176,
but not MTX or DTX, inhibited cell proliferation. This was not a
consequence of the DMSO used as vehicle. Similar results were
obtained with cell number (Fig. 4C). A dose-dependent study
revealed that S0100176 abolished cell growth with a semimax-
imal inhibition (EC50) of 24.1±6.0 μM (Fig. 4D). S0100176 at
concentrations above 100 μM proved to be cytotoxic when cell
viability was assessed by trypan blue exclusion (data not
shown). Since Kv1.5 is involved in myoblast proliferation, we
analysed the cell cycle distribution generated by our pharma-
cological approach. Sub-cytotoxic doses of S0100176 (20 μM),
but not 100 nM MTX or 1 μM DTX (data not shown), arrested
the cells at the G0/G1-phase (Fig. 4E). Thus, while the number of
cells at the G0/G1 phase increased by more than 30%, the
percentage at the S-phase decreased by ∼15%. In addition,
myoblasts at G2/M decreased by about 50%, this being similar to
the G0-arrested culture in the absence of FBS. Similar G0/G1lls were cultured for 24 h in the absence (−FBS) or presence of serum (+FBS)
analysis. Representative histograms after 24 h of FBS re-addition. (B) Cell cycle
in triplicate. (C) Protein expression of cyclins A and D1 and Kv1.5. C, control
anel C. Grey bars, cyclin A; open bars, cyclin D1; closed bars, Kv1.5. Values,
blots. ⁎, pb0.05; ⁎⁎⁎, pb0.001 vs. control (Student's t test).
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Membrane potential changes thoroughly the cell cycle. Pro-
liferating cells are more depolarized but a partial hyperpolariza-
tion in G1/S-phase has been described [2]. Fig. 4F shows
membrane potential changes measured by DiBAC4(3) fluores-
cence. As expected, 75 mM KCl depolarized myoblasts.
Proliferation also depolarized myoblasts, but cells were partially
hyperpolarized around the G1/S boundary (14 h). However, 4-
AP and S0100176 counteracted these changes.
3.5. Control of cell cycle progression by Kv1.5 involves p21cip-1
and p27kip1
Kv1.5 is transiently induced during proliferation and
S0100176, but not MTX and DTX, arrested myoblasts at the
G1-phase. To further characterize whether Kv1.5 may be
required during cell cycle progression we first analysed cyclin
D1 (a G1 marker) [30], cyclin A, which accumulates during the
S-phase [3], and Kv1.5 in the presence or absence of several cell
cycle blockers. Thus, arrested myoblasts (−FBS) induced to
proliferate (+FBS) were incubated for 24 h with mimosine (Mi)
and hydroxyurea (HU). As expected, Mi arrested myoblasts at
the G1-phase, or at the beginning of the S-phase [31], whereas
HU blocked the cell cycle at the S-phase (Fig. 5A and B) [32].
While cyclin A and D1 expression was similar in the presence of
Mi, HU caused significant reduction of both cyclins. It is well
known that cyclin D1 levels begin to rise early in G1 but rapidly
decline at the G1/S boundary [30]. However, the Kv1.5
abundance slightly increased in the presence of Mi and was
further accumulated with HU. These data are in agreement with
a cell cycle-dependent regulation of Kv1.5, thereby accumulat-
ing the channel during the G1-phase.
Once we had determined that cell cycle-dependent regulation
of Kv1.5 was involved in myoblast proliferation, we sought toFig. 6. Blockage of Kv1.5 by S0100176 down-regulates cyclins and accumulates cycl
presence of FBS. Protein expression of cyclins (A and D1), cyclin-dependent kinase
representative Western blots in the absence (control) or presence of 100 μM S010017
β-actin levels to give the relative expression in arbitrary units (AU). Values are the me
S0100176; ○, myoblasts in the presence of S0100176. Statistical differences were
(ANOVA vs. control).analyse possible underlying mechanisms. Fig. 6 shows that the
incubation of proliferating myoblasts with S0100176 modified
p21cip-1 and p27kip1 kinetics (Fig. 6A, D and E). S0100176 led
to faster p21cip-1 accumulation and counteracted the cell cycle-
down-regulation of p27kip1. Concomitantly, an impaired cyclin
A and cyclin D1 modulation was observed (Fig. 6A, B and C).
When cells re-entered the cycle, cyclin D1 increased at G1 and
cyclin A accumulated during G2/M. However, the presence of
S0100176 abolished such modulation. Furthermore, as ex-
pected, the S0100176-dependent G1-arrest accumulated Kv1.5
protein (Fig. 6A and F) and mRNA (not shown).
4. Discussion
We report here the cell cycle-dependent regulation of Kv1.5 in
L6E9myoblasts. Kv1.5 and Kv1.3 increased during the G1-phase
of the cell cycle. In addition, Kv1.5 was involved in skeletal
muscle cell proliferation through a mechanism which includes an
accumulation of cyclin-dependent kinase inhibitors p21cip-1 and
p27kip1, together with a marked decrease of cyclins A and D1. To
date, this is the first report demonstrating that Kv channels, and
specifically Kv1.5, are involved in myoblast proliferation.
4.1. L6E9 myoblasts express Kv1.5 and Kv1.3
Skeletal muscle is formed by different types of fibres with
different contractile and electrical properties. Kv channels
control excitability in myotubes [1]. Kv1.5 and Kv1.3 are
present in skeletal muscle and myoblasts in culture [17,18]. In
agreement with this, we found a high expression of Kv1.5 in
L6E9 cells. Kv1.3, the major Kv in the immune system [25], was
also present. Since Kv1.3 is involved in proliferation [12,13], we
also extended our study to this subunit. Although Kv1.3 behaves
similarly to Kv1.5, it played no apparent role duringin-dependent kinase inhibitors. Resting myoblasts were incubated for 24 h in the
inhibitors (p21cip-1 and p27kip1) and Kv1.5 was analysed at indicated times. (A)
6. (D–F) Quantification of data in panel A. Protein abundance was normalized to
an±SEM of four different assays. Symbols are:●, control cells in the absence of
as follows: cyclin A, D1 and Kv1.5, pb0.001; p21
cip-1 and p27kip1, pb0.05
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contractibility and other processes, such as differentiation, is
further supported by the presence of Kvβ modulatory subunits
[24]. These auxiliary subunits associate to Kv1.5 and fine tune
Kv1.3 during proliferation in macrophages [21,33].
4.2. Cell cycle-dependent regulation of Kv1.5 is important for
myoblast proliferation
Myoblasts withdraw from the cell cycle to form an array of
muscle fibres. However, under certain conditions, some cells re-
enter the cycle [16]. Both Kv1.5 and Kv1.3 were up-regulated
during the G1-phase. Non-selective K
+ channel blockers, such as
TEA and 4-AP, aswell as toxins indicate thatKv play a role during
proliferation [6]. We show that Kv1.5 was involved in myoblast
growth. First, MTX rules out Kv1.3 and Kv1.3/Kv1.5 hetero-
tetramers [13,34], as well as Kv1.1, Kv1.2, Kv1.4 andKv1.6 [27].
Second, DTX blocks the majority of Kv1 subunits but not Kv1.5
[28]. Finally, S0100176, a Kv antagonist which blocks Kv1.5,
halts proliferation and arrests myoblasts at the G1-phase [29].
Although K+channels are involved in myogenesis [17,23,24,
35,36], little is known about their role in myoblast proliferation
[37]. While Kv1.3 controls leukocyte growth, Kv1.5 function is
under debate [4,11–13,15,25,26]. Unlike Kv1.3, Kv1.5 is not
modulated during macrophage proliferation but plays an alter-
native role through heteromeric associations with Kv1.3 during
activation [12,13,34]. This was confirmed in microglia. While
resting microglia express mostly Kv1.5, proliferating cells switch
to a Kv1.3 phenotype [26]. However, Kv1.5 plays a pivotal role
during proliferation in astrocytes [11]. In this context, sharing
Kv1.3 and Kv1.5 expression, myoblasts will resemble astrocytes
more than macrophages.
4.3. Kv1.5 controls myoblast proliferation through a mechanism
that involves p21cip-1 and p27kip1
Several hypotheses could explain the control of the cell cycle
by Kv channels: cell volume, membrane potential and Ca2+
signalling. Kv1.5 is a non-inactivating K+ channel [2,3,8]. Ion
movements are involved in water homeostasis during the cell
cycle. Therefore, in contrast to inactivating Kv1.4, Kv1.5
contributes to cell volume control [38]. In addition, membrane
potential changes during G1 or G1/S transition [2,3,8]. Kv
channels would contribute to control a specific check point
during these stages. In fact, cell volume control and changes in
membrane potential are crucial events for solute electrogenic
uptake during proliferation [39,40]. Furthermore, and similar to
Kv1.3 in lymphocytes, Kv1.5 would trigger enough hyperpo-
larization to promote the exit of Ca2+ from internal reservoirs
and to activate plasma membrane Ca2+ channels, thus initiating
appropriate signalling [25].
Experimental evidence indicates that K+ channels control cell
growth, but further analysis of downstream signalling is scarce
[2,8]. Non-selective K+ channel blockers, such as TEA and 4-AP,
arrest astrocytes in G0/G1 [6]. In addition, TEA increases p21
cip-1
and p27kip1 in platelet-derived growth factor-induced glial cells
[5]. However, the role of Kv1.5 is controversial since the channelis resistant to TEA [14]. In addition, the inhibition of T-cell
proliferation by TEA, 4-AP and σ ligands reveals an association
between K+ channels and p27kip1 accumulation [41]. The cell
cycle progression is regulated positively by cyclins and neg-
atively by CDKIs.While cyclin D1 is involved during the early to
mid-G1 phase, the transition through the G1/S boundary depends
on cyclin A. Furthermore p21cip-1 and p27kip1 control prolifera-
tion, triggering cell cycle arrest [7]. S0100176 increased p21cip-1
and p27kip1 and decreased cyclins A and D1. In this context,
MTX and DTX rule out many Shaker channels. The role played
by CDKIs during myoblast proliferation is crucial. Quiescent
C2C12 myoblasts re-enter the cell cycle by eliminating p21cip-1
[16]. None of the compounds studied is selective, but when the
results are put together they support this conclusion.
Finally, it is intriguing that myoblasts, which are excitable
cells with a wide repertoire of K+ channels, express negligible
voltage-dependent K+ currents [17,35,42]. The major K+ con-
ductance is Ca2+-dependent (data not shown) [35]. Therefore, it
is not known to what extent Kv may control myoblast pro-
liferation. However, Kv1.5 may be crucial when localized as
Kv1.3 in T-lymphocytes [43]. Furthermore, it is tempting to
speculate that in addition to their well-described function in
regulating excitability, Kv-driven signalling pathways could be
independent of ion flux but related to conformational changes
[10]. In C2C12 myoblasts, non-conducting EAG-mutant chan-
nels, which remain in the open conformation, inhibit prolifera-
tion [9]. Recent findings demonstrate that a number of ion
channels exert biological activity that is unrelated to ion con-
duction and cannot be mimicked by other types of ion channel
with similar electrical properties [10].
In summary, Kv1.5 is an upstream modulator of G1-phase
progression in skeletal muscle cells. Pharmacological experi-
ments provide evidence that Kv channels negatively regulate
cyclins A and D1 and accumulate p21
cip-1 and p27kip1. Our
results have physiological significance since myoblast prolif-
eration is of relevance during muscle regeneration, cancer and
cell therapies, such as cardiomyoplasty. These results may
further our understanding of the underlying mechanisms by
which K+ channels govern cell proliferation.
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